$LGND News Article - Ligand's Partner CStone Pharm
Post# of 21199
(Total Views: 83)
Posted On: 12/22/2021 3:15:50 PM
$LGND News Article - Ligand's Partner CStone Pharmaceuticals Receives Approval in China for Sugemalimab (Cejemly ) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer in Combination with Chemotherapy https://marketwirenews.com/news-releases/liga...04884.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼